HSK-205

N/A

Report date: 2023/10/12 17:36:07
NME

Base Information

Drug NameHSK-205
Drug Alias NameHSK205HSK-205
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosine-protein kinase receptor FLT3 inhibitorsSerine/threonine-protein kinase haspin inhibitors
TargetsTyrosine-protein kinase receptor FLT3Serine/threonine-protein kinase haspin
Therapy Area/IndicationsLeukemia, Myeloid, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPurdue University
China Registration ClassN/A

Develop Information

Active CompaniesPurdue University
Inactive CompaniesN/A
Active IndicationsLeukemia, Myeloid, Acute
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A